封面
市场调查报告书
商品编码
1356589

局部给药报告:2030 年趋势、预测与竞争分析

Topical Drug Delivery Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

局部药物传输趋势与预测

预计到 2030 年,全球局部给药市场将达到 3,966 亿美元,2024 年至 2030 年年复合成长率为 8.5%。这个市场的主要促进因素是皮肤相关疾病发生率的增加、烧烫伤相关伤害发生率的增加以及糖尿病患病的上升。全球局部给药市场的未来看起来充满希望,居家医疗环境、医院/诊所和烧烫伤中心市场充满机会。

局部给药市场洞察

Lucintel 预测,半固态製剂由于其在输送不同药理化合物方面的弹性和易用性,将在预测期内实现最高增长。

由于对负担得起且方便的局部药物输送服务的需求不断增长,家庭护理机构将继续成为最大的细分市场。

由于吸烟者数量的增加、对自我给药药物的高需求以及大型製药公司的存在,预计北美在预测期内将出现最高的增长。

本报告回答了 11 个关键问题:

  • Q.1. 细分市场中最有前途和高成长的机会是什么?
  • Q.2.哪个细分市场将以更快的速度成长?为什么?
  • Q.3.您认为哪些地区未来会出现更快的成长?为什么?
  • Q.4. 影响市场动态的主要要素有哪些?市场的主要挑战和商业风险是什么?
  • Q.5. 这个市场的商业风险和竞争威胁是什么?
  • Q.6.这个市场有哪些新趋势?为什么?
  • Q.7.市场客户需求有何改变?
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位?
  • Q.9.这个市场的主要企业有哪些?主要企业采取哪些策略配合措施来发展业务?
  • Q.10. 该市场上的竞争产品有哪些,由于材料或产品替代导致市场占有率下降的威胁有多大?
  • Q.11.过去年度发生了哪些併购事件,对产业产生了哪些影响?

目录

第1章执行摘要

第2章全球局部给药市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球局部给药市场趋势(2018-2023)与预测(2024-2030)
  • 按产品的全球局部给药市场
    • 半固态製剂
    • 液体配方
    • 固态製剂
    • 经皮吸收产品
  • 按给药途径给药的全球局部给药市场
    • 经皮经皮
    • 滴眼剂药物输送
    • 直肠给药
    • 阴道内给药
    • 鼻腔给药
  • 按最终用途行业分類的全球局部给药市场
    • 家庭护理设置
    • 医院和诊所
    • 烧伤中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球局部给药市场(按地区)
  • 北美局部给药市场
  • 欧洲局部给药市场
  • 亚太地区局部给药市场
  • 其他区域性局部给药市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品的全球局部给药市场成长机会
    • 按给药途径分類的全球局部给药市场成长机会
    • 最终用途产业的全球局部给药市场成长机会
    • 全球局部给药市场区域成长机会
  • 全球局部给药市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球局部给药市场的产能扩张
    • 全球局部给药市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Glenmark Pharmaceuticals
  • Galderma
  • Johnson & Johnson
  • GlaxoSmithkline
  • Bausch Health
  • Hisamitsu Pharmaceuticals
  • Cipla
  • Bayer
  • Viatris
  • 3M
简介目录

Topical Drug Delivery Trends and Forecast

The future of the global topical drug delivery market looks promising with opportunities in the home care settings, hospitals & clinics, and burn centers markets. The global topical drug delivery market is expected to reach an estimated $396.6 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are increasing frequency of skin related diseases, growing incidence of burn related injuries, and rising prevalence of diabetes.

A more than 150-page report is developed to help in your business decisions.

Topical Drug Delivery by Segment

The study includes a forecast for the global topical drug delivery by product, route of administration, end use industry, technology, and region.

Topical Drug Delivery Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Semi-Solid Formulations
  • Liquid Formulations
  • Solid Formulations
  • Transdermal Products

Topical Drug Delivery Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Dermal Drug Delivery
  • Ophthalmic Drug Delivery
  • Rectal Drug Delivery
  • Vaginal Drug Delivery
  • Nasal Drug Delivery

Topical Drug Delivery Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Home Care Settings
  • Hospitals & Clinics
  • Burn Centers
  • Others

Topical Drug Delivery Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Topical Drug Delivery Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies topical drug delivery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the topical drug delivery companies profiled in this report include-

  • Glenmark Pharmaceuticals
  • Galderma
  • Johnson & Johnson
  • GlaxoSmithkline
  • Bausch Health
  • Hisamitsu Pharmaceuticals
  • Cipla
  • Bayer
  • Viatris
  • 3M

Topical Drug Delivery Market Insights

Lucintel forecast that semi-solid formulations is expected to witness highest growth over the forecast period due to its flexibility in delivering different pharmacological compounds and ease of use.

Home care settings will remain the largest segment due to increasing need for affordable and convenient topical drug delivery services in this setting.

North America is expected to witness highest growth over the forecast period due to growing number of smokers, high demand for self-administered medications, and presence of key pharmaceutical players in the region.

Features of the Global Topical Drug Delivery Market

Market Size Estimates: Topical drug delivery market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Topical drug delivery market size by product, route of administration, end use industry, and region. in terms of value ($B).

Regional Analysis: Topical drug delivery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, route of administrations, end use industries, and region.s for the topical drug delivery market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the topical drug delivery market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the topical drug delivery market size?

Answer: The global topical drug delivery market is expected to reach an estimated $396.6 billion by 2030.

Q.2. What is the growth forecast for topical drug delivery market?

Answer: The global topical drug delivery market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the topical drug delivery market?

Answer: The major drivers for this market are increasing frequency of skin related diseases, growing incidence of burn related injuries, and rising prevalence of diabetes.

Q.4. What are the major segments for topical drug delivery market?

Answer: The future of the topical drug delivery market looks promising with opportunities in the home care settings, hospitals & clinics, and burn centers markets.

Q.5. Who are the key topical drug delivery market companies?

Answer: Some of the key topical drug delivery companies are as follows:

  • Glenmark Pharmaceuticals
  • Galderma
  • Johnson & Johnson
  • GlaxoSmithkline
  • Bausch Health
  • Hisamitsu Pharmaceuticals
  • Cipla
  • Bayer
  • Viatris
  • 3M

Q.6. Which topical drug delivery market segment will be the largest in future?

Answer: Lucintel forecast that semi-solid formulations is expected to witness highest growth over the forecast period due to its flexibility in delivering different pharmacological compounds and ease of use.

Q.7. In topical drug delivery market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing number of smokers, high demand for self-administered medications, and presence of key pharmaceutical players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the topical drug delivery market by product (semi-solid formulations, liquid formulations, solid formulations, and transdermal products), route of administration (dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery, and nasal drug delivery), end use industry (home care settings, hospitals & clinics, burn centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Topical Drug Delivery Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Topical Drug Delivery Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Topical Drug Delivery Market by Product
    • 3.3.1: Semi-Solid Formulations
    • 3.3.2: Liquid Formulations
    • 3.3.3: Solid Formulations
    • 3.3.4: Transdermal Products
  • 3.4: Global Topical Drug Delivery Market by Route of Administration
    • 3.4.1: Dermal Drug Delivery
    • 3.4.2: Ophthalmic Drug Delivery
    • 3.4.3: Rectal Drug Delivery
    • 3.4.4: Vaginal Drug Delivery
    • 3.4.5: Nasal Drug Delivery
  • 3.5: Global Topical Drug Delivery Market by End Use Industry
    • 3.5.1: Home Care Settings
    • 3.5.2: Hospitals & Clinics
    • 3.5.3: Burn Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Topical Drug Delivery Market by Region
  • 4.2: North American Topical Drug Delivery Market
    • 4.2.1: North American Topical Drug Delivery Market by Product: Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.2.2: North American Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
  • 4.3: European Topical Drug Delivery Market
    • 4.3.1: European Topical Drug Delivery Market by Product: Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.3.2: European Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
  • 4.4: APAC Topical Drug Delivery Market
    • 4.4.1: APAC Topical Drug Delivery Market by Product:Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.4.2: APAC Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
  • 4.5: ROW Topical Drug Delivery Market
    • 4.5.1: ROW Topical Drug Delivery Market by Product:Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
    • 4.5.2: ROW Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Topical Drug Delivery Market by Product
    • 6.1.2: Growth Opportunities for the Global Topical Drug Delivery Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Topical Drug Delivery Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Topical Drug Delivery Market Region
  • 6.2: Emerging Trends in the Global Topical Drug Delivery Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Topical Drug Delivery Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Topical Drug Delivery Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Glenmark Pharmaceuticals
  • 7.2: Galderma
  • 7.3: Johnson & Johnson
  • 7.4: GlaxoSmithkline
  • 7.5: Bausch Health
  • 7.6: Hisamitsu Pharmaceuticals
  • 7.7: Cipla
  • 7.8: Bayer
  • 7.9: Viatris
  • 7.10: 3M